PRVA Q1 2026 Earnings EPS Falls Short of Consensus Amid Operating Headwinds Scinai Immunotherapeutics SCNI Q4 2023 Earnings NarrowerThanExpected Loss Amid Operational Adjustments SPB Q1 2026 Earnings EPS Surpasses Estimates by 127 Stock Declines 14 Core Laboratories Q1 2026 Earnings EPS Misses Estimates as Market Challenges Persist VNET Q4 2025 Earnings Massive EPS Surprise of 296 Despite Revenue Uncertainty Buda Juice Inc BUDA Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency